Sysmex (OTCMKTS:SSMXY) Announces FY 2026 Earnings Guidance

Sysmex (OTCMKTS:SSMXY) updated its FY 2026 earnings guidance on Tuesday morning. The company provided earnings per share guidance of 0.415-0.415 for the period, compared to the consensus EPS estimate of 0.440. The company issued revenue guidance of $3.5 billion, compared to the consensus revenue estimate of $3.1 billion.

Wall Street Analyst Weigh In

Separately, Zacks Research raised Sysmex from a “strong sell” rating to a “hold” rating in a report on Tuesday, August 18th. Two investment analysts have rated the stock with a Hold rating. According to MarketBeat.com, the stock has a consensus rating of “Hold”.

Sysmex Stock Down 3.9%

SSMXY stock opened at $12.83 on Thursday. The company has a market cap of $7.81 billion, a price-to-earnings ratio of 35.64 and a beta of 1.20. The company has a fifty day moving average price of $12.04 and a 200 day moving average price of $10.06. The company has a debt-to-equity ratio of 0.23, a current ratio of 3.40 and a quick ratio of 2.53. Sysmex has a 12 month low of $8.01 and a 12 month high of $13.75.

Sysmex (OTCMKTS:SSMXY) last released its quarterly earnings results on Tuesday, November 10th. The company reported $0.10 EPS for the quarter, hitting the consensus estimate of $0.10. The business had revenue of $895.73 million during the quarter, compared to analysts’ expectations of $859.71 million. Sysmex had a return on equity of 6.81% and a net margin of 6.38%. Sysmex has set its FY 2026 guidance at 0.415-0.415 EPS. Sell-side analysts expect that Sysmex will post 0.41 earnings per share for the current year.

Sysmex Company Profile

Sysmex Corporation is a Japan-based healthcare technology company that develops, manufactures and sells diagnostic testing instruments, reagents and related services. Its products are used by hospitals, clinical laboratories and other healthcare providers to analyze patient samples and support medical diagnosis. The company is best known for its hematology testing systems and also offers products for hemostasis, urinalysis, clinical chemistry and immunochemistry, as well as laboratory information systems and support services.